Houlihan Lokey Advises Revelstoke Capital Partners Fund III

Houlihan Lokey is pleased to announce that Revelstoke Capital Partners Fund III and affiliated entities closed on $1.7 billion of commitments, exceeding its target of $1.0 billion.

Revelstoke Capital Partners (Revelstoke) completed the successful fundraising for its third flagship fund, Revelstoke Capital Partners Fund III, LP (the “Fund”) and various affiliated investment vehicles totaling $1.7 billion. The Fund enables Revelstoke to continue its strategy of building industry-leading companies in the U.S. healthcare and related health and wellness sectors. The Fund was raised with strong support from Revelstoke’s existing limited partners and a group of new relationships comprising pension funds, sovereign wealth funds, consultants, endowments, and family offices from across the globe.

Founded in 2013, Revelstoke has approximately $5.8 billion of assets under management and has completed 184 acquisitions, which include 26 platform companies and 158 add-ons acquisitions. Revelstoke partners with entrepreneurs and management teams to execute a disciplined organic and acquisition growth strategy as it strives to build exceptional U.S. healthcare companies.

Houlihan Lokey’s Private Funds Group served as Revelstoke’s lead placement agent and advised on the marketing and solicitation of the offering globally. This marquee transaction was the fifth fund raised with Revelstoke and highlights Houlihan Lokey’s success in delivering superior results in a difficult market.